We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+5.02%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
–
AUM
$1.05B
AUM Growth
+$9.85M
Cap. Flow
+$95.1M
Cap. Flow %
9.1%
Top 10 Hldgs %
50%
Holding
874
New
223
Increased
214
Reduced
73
Closed
220

Top Buys

Rank Stock Value
1
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$54.9M
2
IMCR icon
Immunocore
IMCR
+$48.2M
3
ARKK icon
ARK Innovation ETF
ARKK
+$41.6M
4
TWTR
Twitter, Inc.
TWTR
+$36.7M
5
RNAM
Avidity Biosciences
RNAM
+$29.2M

Top Sells

Rank Stock Value
1
RLMD icon
Relmada Therapeutics
RLMD
+$23.6M
2
PSTH
Pershing Square Tontine Holdings, Ltd.
PSTH
+$19M
3
RBAC
RedBall Acquisition Corp.
RBAC
+$12.5M
4
SMFG icon
Sumitomo Mitsui Financial
SMFG
+$12.1M
5
STOK icon
Stoke Therapeutics
STOK
+$11.8M

Sector Composition

Rank Sector Weight
1 Healthcare 34.11%
2 Financials 8.03%
3 Materials 6.97%
4 Technology 3.58%
5 Industrials 3.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PSQH.WS icon
351
PSQ Holdings, Inc. Warrants, Each whole warrant exercisable for 1/15th of a share of Class A common stock at an exercise price of $172.50 per share
PSQH.WS
$1.27M
$17K ﹤0.01%
154,544
+101,300
+190% +$9.9K
SHPWW
352
DELISTED
Shapeways Holdings, Inc. Warrants
SHPWW
$17K ﹤0.01%
352,272
+5,100
+1% +$358
ROSS.WS
353
DELISTED
Ross Acquisition Corp II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
ROSS.WS
$17K ﹤0.01%
217,695
+39,041
+22% +$4.9K
ZINGW
354
DELISTED
FTAC Zeus Acquisition Corp. Warrant
ZINGW
$17K ﹤0.01%
171,317
+30,570
+22% +$4.39K
FMIVW
355
DELISTED
Forum Merger IV Corporation Warrant
FMIVW
$17K ﹤0.01%
+285,244
New +$38.7K
PDOT.WS
356
DELISTED
Peridot Acquisition Corp. II Redeemable warrants included as part of the units, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
PDOT.WS
$17K ﹤0.01%
+167,334
New +$20.9K
GACQW
357
DELISTED
Global Consumer Acquisition Corp. Warrant
GACQW
$17K ﹤0.01%
129,509
– –
VMCAW
358
DELISTED
Valuence Merger Corp. I Warrant
VMCAW
$16K ﹤0.01%
100,000
– –
EVGRW
359
DELISTED
Evergreen Corporation Warrant
EVGRW
$16K ﹤0.01%
264,195
– –
ZURAW
360
DELISTED
Zura Bio Limited Warrants
ZURAW
$16K ﹤0.01%
97,966
+77,266
+373% +$14.3K
UTAAW
361
DELISTED
UTA Acquisition Corporation Warrants
UTAAW
$16K ﹤0.01%
73,990
+58,990
+393% +$18.1K
SVNAW
362
DELISTED
7 Acquisition Corp Warrant
SVNAW
$16K ﹤0.01%
116,134
– –
GTPBW
363
DELISTED
Gores Technology Partners II, Inc. Warrant
GTPBW
$16K ﹤0.01%
+99,800
New +$25K
YOTAW
364
DELISTED
Yotta Acquisition Corporation Warrant
YOTAW
$15K ﹤0.01%
+386,900
New +$19.3K
LCAHW
365
DELISTED
Landcadia Holdings IV, Inc. Warrant
LCAHW
$15K ﹤0.01%
99,900
+59,383
+147% +$9.85K
TRAQ.WS
366
DELISTED
Trine II Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share
TRAQ.WS
$15K ﹤0.01%
135,101
+200
+0.1% +$31
NOVVR
367
DELISTED
Nova Vision Acquisition Corp. Rights
NOVVR
$15K ﹤0.01%
100,100
+49,201
+97% +$5.91K
QBTS.WS
368
DELISTED
D-Wave Quantum Inc Warrants
QBTS.WS
$14K ﹤0.01%
+43,914
New +$21K
SKIN icon
369
SkinHealth Systems
SKIN
$91.1M
$14K ﹤0.01%
+20,000
New +$253K
ATAKR
370
DELISTED
Aurora Technology Acquisition Corp. Rights
ATAKR
$14K ﹤0.01%
234,349
– –
ACAQ.WS
371
DELISTED
Athena Consumer Acquisition Corp. Redeemable warrants included as part of the units, each whole warrant exercisable for one share of Class A common stock for $11.50 per share
ACAQ.WS
$14K ﹤0.01%
+272,947
New +$38.9K
EPHYW
372
DELISTED
Epiphany Technology Acquisition Corp. Warrant
EPHYW
$14K ﹤0.01%
+227,193
New +$15.9K
AGAC.WS
373
DELISTED
African Gold Acquisition Corp Warrants
AGAC.WS
$14K ﹤0.01%
349,501
+103,152
+42% +$6.21K
BOAS.WS
374
DELISTED
BOA Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at a price of $11.50 per share
BOAS.WS
$14K ﹤0.01%
60,236
+26,903
+81% +$5.52K
LNZAW icon
375
LanzaTech Global Warrant
LNZAW
$13K ﹤0.01%
+89,697
New +$16.6K
13 14
15
16 17

Similar funds

CIP
Chartwell Investment Partners Berywn, Pennsylvania $2.91B AUM 40.48% 1-Year Est. Return
PWLP
Prio Wealth Limited Partnership Boston, Massachusetts $3.41B AUM 44.09% 1-Year Est. Return
FPCG
Fort Pitt Capital Group Pittsburgh, Pennsylvania $3.55B AUM 34.86% 1-Year Est. Return
SI
Scout Investments Kansas City, Missouri $3.8B AUM 45.91% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
FTDI
First Trust Direct Indexing Boston, Massachusetts $1.87B AUM 43.63% 1-Year Est. Return
CIM
Contrarius Investment Management St. Helier, Jersey $1.76B AUM 35.87% 1-Year Est. Return
PRO
Pensioenfonds Rail & OV Utrecht, Netherlands $1.44B AUM 23.73% 1-Year Est. Return

Cowen and Company's Q3 2022 Portfolio in Review

As of Q3 2022, Cowen and Company held 874 positions worth $1.05B, up 0.95% from $1.04B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Cowen and Company deployed $95.1M of net new capital in Q3 2022, opening 223 new positions and adding to 214 existing holdings. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 726,608 shares worth $20.8M.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 29% a quarter earlier, followed by Financials and Materials.

On the sell side, the largest reduction was Relmada Therapeutics, an estimated $23.6M trimmed.

  • Cowen and Company's largest Q3 2022 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 726,608 shares worth $20.8M.
  • Cowen and Company added most to ARK Innovation ETF in Q3 2022, an estimated $41.6M increase.
  • Cowen and Company's biggest Q3 2022 reduction was Relmada Therapeutics, cutting an estimated $23.6M.
  • Cowen and Company fully exited Pershing Square Tontine Holdings, Ltd. in Q3 2022, selling an estimated $19M.
  • Cowen and Company's ten largest holdings make up 50% of its $1.05B portfolio in Q3 2022.
  • Cowen and Company opened 223 new positions and closed 220 in Q3 2022.
  • Cowen and Company's portfolio value rose 0.95% quarter-over-quarter to $1.05B.

Based on Cowen and Company's 13F filing for Q3 2022, filed 14 Nov 2022.